[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Characterizing, Collecting, and Reporting Immune-Mediated A...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Tissue Agnostic Drug Development in Oncology.[ Price : $8.95]
FDA warns Pearland, TX-based Forcemech International about Quality System and other violations in its importation and distribution...[ Price : $8.95]
FDA awards 19 grants and two contracts to support new medical products to treat rare diseases.[ Price : $8.95]
CDRH publishes its A- and B-List proposed guidances to be published in FY 2023 with a retrospective list of guidances published in...[ Price : $8.95]
FDA and academic researchers say the representation of older adults in clinical trials should be improved.[ Price : $8.95]
Three stakeholders suggest specific changes to Appendix A of the ANDA Amendments guidance as called for in the GDUFA 3 negotiation...[ Price : $8.95]
FDA commissioner Robert Califf tells the 2022 National Organization for Rare Disorders Breakthrough Summit that improvements in th...